Patients

The EUPHORIA study highlighted in German IBD patient advocacy magazine, Bauchredner

The EUPHORIA study highlighted in German IBD patient advocacy magazine, Bauchredner

By euphoria_admin|2022-05-09T11:20:41+01:00May 9th, 2022|

The Deutsche Morbus Crohn's/Colitis Ulcerosa Vereinigung, or DCCV (https://www.dccv.de/) highlighted the EUPHORIA study in their February 2021 publication, Bauchredner. The five-page article can be downloaded here, or read in the images below. The German Crohn's Disease/Ulcerative Colitis Association (DCCV) eV is the patient advocacy association for over 400,000 people with chronic inflammatory bowel disease ( IBD ) in [...]

Your privacy

We use cookies to improve your experience on this website. We never show advertisements, but do share content from third-parties (e.g. videos). Data about your interaction with the site is used to improve the content that we share.

You can change your mind at any time by updating your settings. Please let us know if you agree.
Cookie Settings Accept

Tracking Cookies

We use Google Analytics to help us improve our website by collecting information on how you use this site. The cookies collect information without directly identifying you. You can read more about our use of Google Analytics on our Privacy Policy.

Tracking Cookies

Third Party Embeds

Pages on this site may include embedded content (e.g. YouTube videos). Embedded content behaves in the same way as if a user had visited that site and these websites may collect data about you. To learn more please visit our Privacy Policy.

YouTube
X

Necessary

Necessary cookies help make a website usable by enabling basic functions. The website cannot function properly without these cookies. You may disable these by changing your browser settings but this will affect how the website functions.

Our Privacy Policy

We respect your privacy. Our site uses several third-party services. Please select which cookies you would like to allow by selecting the checkboxes. To learn more or update your settings please visit our Privacy Policy. Thank you.